Today, 28th of February, Fondazione Telethon (Italy) launched a Press Release to announce the agreement between Fondazione Telethon and Orchard Therapeutics, under which the foundation will work to make gene therapy for Wiskott-Aldrich syndrome available to patients.
Read the Press Release here: https://www.telethon.it/en/stories-and-news/news/from-telethon-foundation/fondazione-telethon-announces-commitment-to-make-gene-therapy-for-wiskott-aldrich-syndrome-available-to-patients